A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity - AsiaOne

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and …

LONDON, June 15, 2022 (GLOBE NEWSWIRE) -- With over 460 million global cases thus far, 6 million of which have resulted in death, the COVID-19 pandemic from SARS-CoV-2 proved to be a dire health cris… [+4838 chars]

full article...